Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
XERS
Stock Latest News
Company Announcements
Xeris Biopharma Announces Board Transition as Director Retires
14d ago
8K
XERS
Premium
Company Announcements
Xeris Pharmaceuticals Earnings Call Highlights Rapid Growth
2M ago
XERS
Premium
TipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
2M ago
NSRX
XERS
Premium
The Fly
Xeris Biopharma reports Q4 revenue 6c vs. (3c) last year
2M ago
XERS
Premium
The Fly
Xeris Biopharma sees FY26 revenue $375M-$390M, consensus $368M
2M ago
XERS
Premium
Pre-Earnings
Xeris Pharmaceuticals (XERS) Q4 Earnings Cheat Sheet
2M ago
XERS
Premium
The Fly
Xeris Biopharma subsidiaries file Recorlev patent infringement lawsuit
2M ago
XERS
Premium
Market News
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
2M ago
COF
VIR
Premium
Ratings
Xeris Biopharma: Strong 2025 Outperformance and Underappreciated Multiyear Growth Drive Buy Rating
4M ago
XERS
Premium
The Fly
Xeris Biopharma initiated with an Overweight at Barclays
5M ago
XERS
Premium
Company Announcements
Xeris Pharmaceuticals Secures Patent Allowance for XP-8121
5M ago
8K
XERS
Premium
The Fly
Xeris Biopharma issued notice of allowance from USPTO for XP-8121
5M ago
XERS
Premium
The Fly
Xeris Biopharma price target raised to $8 from $6 at Piper Sandler
6M ago
XERS
Premium
Ratings
Xeris Pharmaceuticals: Strong Growth Potential and First Profitable Quarter Drive Buy Rating
6M ago
XERS
Premium
Company Announcements
Xeris Biopharma Reports Strong Q3 2025 Financial Results
6M ago
XERS
Premium
Company Announcements
Xeris Biopharma Reports Record Revenue Growth in Earnings Call
6M ago
XERS
Premium
The Fly
Xeris Biopharma reports Q3 EPS 0c, consensus 0c
6M ago
XERS
Premium
The Fly
Xeris Biopharma price target raised to $18 from $8 at Oppenheimer
6M ago
XERS
Premium
The Fly
American Regent launches Gvoke VialDx
8M ago
XERS
Premium
The Fly
Xeris Biopharma announces Orange Book listing of U.S. patent for Recorlev
8M ago
XERS
Premium
Company Announcements
Xeris Pharmaceuticals Reports Record Revenue and Growth
9M ago
XERS
Premium
Ratings
Xeris Pharmaceuticals: Undervalued Growth Potential Driven by Recorlev and XP-8121
9M ago
XERS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
